|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/5377 | |
| A61K 45/06 | |||
| A61P 35/00 | |||
| A61K 31/44 | |||
| A61K 31/506 |
| (11) | Patento numeris | 3215158 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15795318.3 |
| Europos patento paraiškos padavimo data | 2015-11-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-09-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-05-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/059512 |
| Data | 2015-11-06 |
| (87) | Numeris | WO 2016/073877 |
| Data | 2016-05-12 |
| (30) | Numeris | Data | Šalis |
| 201462077127 P | 2014-11-07 | US |
| (72) |
BEEHARRY, Neil, US
GAYLE, Sophia, US
LANDRETTE, Sean, US
BECKETT, Paul, US
CONRAD, Chris, US
XU, Tian, US
ROTHBERG, Jonathan, M., US
LICHENSTEIN, Henri, US
|
| (73) |
AI Therapeutics, Inc.,
530 Old Whitfield Street, Guilford, CT 06437,
US
|
| (54) | APILIMOD FOR USE IN THE TREATMENT OF RENAL CANCER |
| APILIMOD FOR USE IN THE TREATMENT OF RENAL CANCER |